VRNA NASDAQ
Verona Pharma plc
1W: +0.3%
1M: +0.6%
3M: +23.1%
1Y: +272.4%
3Y: +1033.7%
5Y: +1517.4%
$106.91
Last traded 2025-10-06 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
Income Trends
Revenue
$34M
+0.0% ▲
Gross Profit
$32M
+0.0% ▲
Operating Income
-$124M
-133.0% ▼
Net Income
-$139M
-224.8% ▼
EPS (Diluted)
$-1.73
-208.9% ▼
EBITDA
-$120M
-132.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $30M | $379K | $0 | $34M |
| YoY Growth | +0.0% | +0.0% | -98.7% | -100.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $286K | $0 | $2M |
| Gross Profit | $0 | $30M | $93K | $0 | $32M |
| Gross Margin | — | 100.0% | 24.5% | — | 93.9% |
| R&D Expenses | $33M | $59M | $41M | $14M | $36M |
| SG&A Expenses | $22M | $25M | $22M | $39M | $120M |
| Operating Expenses | $54M | $84M | $63M | $53M | $155M |
| Operating Income | -$54M | -$54M | -$63M | -$53M | -$124M |
| Operating Margin | — | -183.3% | -16539.3% | — | -365.7% |
| Interest Expense | $35K | $340K | $521K | $2M | $24M |
| Income Before Tax | -$48M | -$41M | -$57M | -$42M | -$130M |
| Tax Expense | $107K | -$13K | $209K | $372K | $8M |
| Net Income | -$48M | -$41M | -$57M | -$43M | -$139M |
| Net Margin | — | -138.9% | -15000.2% | — | -410.2% |
| EPS (Diluted) | $-1.45 | $-0.69 | $-0.86 | $-0.56 | $-1.73 |
| EBITDA | -$48M | -$42M | -$54M | -$52M | -$120M |
| Shares Outstanding | 33M | 59M | 66M | 79M | 82M |